Fritz Hoffmann-La Roche has founded Rochein 1896. he believed that the industrial manufacture of medicines would be a major advance in the fight against the disease. At the start, Rocher was the successor company to Hoffmann, Traub & Co but it has started to grow into one of the world’s leading healthcare companies.
This Swiss multinational healthcare company with headquarters in Basel is active in over 100 countries and in 2017 employed about 94,000 people worldwide. The aims of the company are Searching for better ways to prevent, diagnose and treat diseases and also Improving the accessibility of drugs for all patients.
Thirty medicines developed and produced by Roche such as life-saving antibiotics, antimalarials, and cancer medicines are included in the World Health Organization Model Lists. Dow Jones Sustainability Indices (DJSI) declared Roche as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry for nine years.
Genentech (the American biotechnology company), Chugai Pharmaceuticals (the Japanese biotechnology company), and American Ventana are all controlled by Roche. Roche is the third-largest pharma supplier and distributor company worldwide; it is also the world leader in in-vitro diagnostics and tissue-based cancer diagnostics.
Here are the most important events during the history of Roche, one of the greatest pharmaceutical suppliers and wholesalers in the world:
1896: The foundation of the company by Fritz Hoffmann-La Rochel; production of various vitamin preparations and derivatives.
1934: Mass-produce synthetic vitamin C( Redoxon).
1957: Sells several drugs for cancer; becoming the leader of this field
1976: An accident at a chemical factory in Seveso, Italy that caused large dioxin contamination.
1982: Acquiring of Biomedical Reference Laboratories by the United States arm of the company: establishment of Roche Biomedical Laboratories, Inc.
1996: Manufacture Oseltamivir the primary antiviral drug used to combat avian influenza/ bird flu.
2009: Acquiring Memory Pharmaceuticals Corp and Genentech.
2015: Acquiring Trophos, GeneWEAVE, Kapa Biosystems, and Adheron Therapeutics.
In January 2016: The company announced it would acquire Tensha Therapeutics for $115 million upfront, with $420 million in contingent payments.
2017: Acquiring ForSight Labs, mySugr, and also Ignyta Inc, expanding its global oncology business.
2018: Acquire Flatiron Health, a business specializing in US cancer data analytics.
Areas that Roche works on them can be divided as follows:
- Infectious diseases
- Cardiovascular and metabolism
- Roche in Hemophilia
Oncology is one of the most important areas that Roche works on it. Roche is the World leader in innovative cancer drugs. It has some innovative cancer drugs on the market.
Herceptin, Avastin, MabThera/Rituxan, Xeloda, and Tarceva are five of these drugs that give patients time to live, they are very beneficial for cancers and each of them has its own unique mechanism. This great pharmaceutical supplier also supplies some therapies that ease the possible side effects of cancer treatment.
Top 10 Pharmaceutical Companies in 2016-2022
One of the three leading therapeutic areas worldwide is the oncology market. Here the oncology market shares of the top ten pharmaceutical companies worldwide in 2016 and 2022 are shown. As you can see Roche is located at top of these pharmaceutical suppliers and also wholesalers. According to this prediction, it will remain as the number one till 2022.
Distribution of Roche’s Pharmaceuticals Division
The revenue distribution of Roche’s Pharmaceuticals division from 2013 to 2017 is shown according to the therapeutic area in the following Statistics. The leading therapeutic area of the Pharmaceuticals Division was oncology in 2013 that generate 62 percent of the division’s total revenues.